Nicotinic acid and schizophrenia: a critique
Publication
, Journal Article
Raft, D; Davidson, J; Spencer, RF
Published in: Clinical Medicine
January 1, 1975
Nicotinic acid therapy of schizophrenia has not been validated to date. While in small doses nicotinic acid is harmless, in doses recommended for treatment of schizophrenia, side reactions are common and occasionally may be serious.
Duke Scholars
Published In
Clinical Medicine
ISSN
1470-2118
Publication Date
January 1, 1975
Volume
82
Issue
4
Start / End Page
15 / 18
Related Subject Headings
- General Clinical Medicine
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Raft, D., Davidson, J., & Spencer, R. F. (1975). Nicotinic acid and schizophrenia: a critique. Clinical Medicine, 82(4), 15–18.
Raft, D., J. Davidson, and R. F. Spencer. “Nicotinic acid and schizophrenia: a critique.” Clinical Medicine 82, no. 4 (January 1, 1975): 15–18.
Raft D, Davidson J, Spencer RF. Nicotinic acid and schizophrenia: a critique. Clinical Medicine. 1975 Jan 1;82(4):15–8.
Raft, D., et al. “Nicotinic acid and schizophrenia: a critique.” Clinical Medicine, vol. 82, no. 4, Jan. 1975, pp. 15–18.
Raft D, Davidson J, Spencer RF. Nicotinic acid and schizophrenia: a critique. Clinical Medicine. 1975 Jan 1;82(4):15–18.
Published In
Clinical Medicine
ISSN
1470-2118
Publication Date
January 1, 1975
Volume
82
Issue
4
Start / End Page
15 / 18
Related Subject Headings
- General Clinical Medicine
- 1103 Clinical Sciences